Literature DB >> 2473118

Significance of the recognition of certain antigenic regions on the human thyroglobulin molecule by natural autoantibodies from healthy subjects.

M Bouanani1, M Piechaczyk, B Pau, M Bastide.   

Abstract

We have evaluated the epitope specificity of natural antihuman thyroglobulin (hTg) autoantibodies (aAb) in the plasma of healthy individuals. By an indirect ELISA technique, we selected 56 plasma samples with high anti-hTg antibody activity and used the IgG fraction isolated from these plasma to study the antigenic domains on the hTg molecule recognized by the natural anti-hTg aAb. A panel of 15 mAb, coupled to alkaline phosphatase and recognizing six regions (I to VI) on the hTg molecule, served to identify the domains recognized by the natural anti-hTg aAb using a competitive ELISA procedure. A total of 26 of the IgG fractions was found to interact with at least one of the regions defined by our battery of mAb. Region V was recognized by the majority of the IgG fractions. Interestingly, region II was rarely recognized by the same IgG fraction that reacted with region V. Inasmuch as we have previously shown that region II is mainly recognized by aAb in the serum of subjects with various thyroid disorders, we propose that recognition of region V reflects the normal physiologic state of the immune system with respect to the hTg molecule.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473118

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Heterogeneity of the thyroglobulin epitopes associated with circulating thyroid hormone autoantibodies in hashimoto's thyroiditis and non-autoimmune thyroid diseases.

Authors:  S Benvenga; C L Burek; M Talor; N R Rose; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

2.  Population dynamics of natural antibodies in normal and autoimmune individuals.

Authors:  F Varela; A Andersson; G Dietrich; A Sundblad; D Holmberg; M Kazatchkine; A Coutinho
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

3.  An autoimmuno-dominant thyroglobulin epitope characterized by a monoclonal antibody.

Authors:  E Schulz; G Benker; H Bethäuser; L Stempka; M Hüfner
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

Review 4.  Thyroglobulin as an autoantigen: what can we learn about immunopathogenicity from the correlation of antigenic properties with protein structure?

Authors:  Fabrizio Gentile; Marisa Conte; Silvestro Formisano
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

5.  Antibodies to acetylcholinesterase cross-reacting with thyroglobulin in myasthenia gravis and Graves's disease.

Authors:  D G Mappouras; G Philippou; S Haralambous; S J Tzartos; A Balafas; A Souvatzoglou; P Lymberi
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

6.  Tryptic peptides of human thyroglobulin: I. Immunoreactivity with murine monoclonal antibodies.

Authors:  A M Saboori; C L Burek; N R Rose; H S Bresler; M Talor; R C Kuppers
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

7.  Changes in anti-thyroglobulin IgG glycosylation patterns in Hashimoto's thyroiditis patients.

Authors:  Shanshan Yuan; Qianqian Li; Yang Zhang; Chuncui Huang; Hongmei Wu; Yan Li; Yalei Liu; Nan Yu; Hong Zhang; Guizhi Lu; Yanming Gao; Ying Gao; Xiaohui Guo
Journal:  J Clin Endocrinol Metab       Date:  2014-11-07       Impact factor: 5.958

8.  Characterization of a new highly sensitive immunometric assay for thyroglobulin with reduced interference from autoantibodies.

Authors:  Marianne Nordlund Broughton; Ragnhild Nome; Ingvill Sandven; Elisabeth Paus; Trine Bjøro
Journal:  Tumour Biol       Date:  2015-12-22

Review 9.  Immunoregulation by naturally occurring and disease-associated autoantibodies : binding to cytokines and their role in regulation of T-cell responses.

Authors:  Claus H Nielsen; Klaus Bendtzen
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.